Pancreas, Gallbladder, Kidney, and Gastrointestinal Safety Questions Approved GLP-1 and GLP-1/GIP therapies include warnings or precautions related to issues such as pancreatitis, gallbladder disease, acute kidney injury, severe gastrointestinal reactions, and hypersensitivity, depending on product labeling [12], [13]
Monthly persistency erosion is steeper in obesity: Obesity GLP-1s drop to 32% persistence over 13 months, compared to 41% for diabetes
Whether you are taking a GLP-1 receptor agonist or other medications or just getting started on your weight loss journey, eating more of the foods called out in this post is a great place to start
Daytime drowsiness occurs if the PM capsule is taken very late at night without adequate sleep hours
However, Inzucchi suggested that younger patients and those without hypertension may benefit from semaglutide for stroke prevention